S&P 500   3,956.28 (-0.18%)
DOW   33,659.02 (-0.36%)
QQQ   284.39 (+0.19%)
AAPL   143.99 (+0.94%)
MSFT   247.33 (-0.03%)
META   116.77 (+1.25%)
GOOGL   93.64 (-0.07%)
AMZN   89.65 (-0.77%)
TSLA   180.68 (+4.17%)
NVDA   173.09 (+0.82%)
NIO   12.76 (-4.85%)
BABA   91.55 (-2.78%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.56 (+0.65%)
CGC   2.91 (-5.83%)
F   13.24 (+0.91%)
GE   82.10 (-1.83%)
DIS   94.03 (+1.60%)
AMC   5.89 (-2.97%)
PYPL   73.88 (-0.46%)
PFE   51.95 (+0.33%)
NFLX   322.75 (+4.03%)
S&P 500   3,956.28 (-0.18%)
DOW   33,659.02 (-0.36%)
QQQ   284.39 (+0.19%)
AAPL   143.99 (+0.94%)
MSFT   247.33 (-0.03%)
META   116.77 (+1.25%)
GOOGL   93.64 (-0.07%)
AMZN   89.65 (-0.77%)
TSLA   180.68 (+4.17%)
NVDA   173.09 (+0.82%)
NIO   12.76 (-4.85%)
BABA   91.55 (-2.78%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.56 (+0.65%)
CGC   2.91 (-5.83%)
F   13.24 (+0.91%)
GE   82.10 (-1.83%)
DIS   94.03 (+1.60%)
AMC   5.89 (-2.97%)
PYPL   73.88 (-0.46%)
PFE   51.95 (+0.33%)
NFLX   322.75 (+4.03%)
S&P 500   3,956.28 (-0.18%)
DOW   33,659.02 (-0.36%)
QQQ   284.39 (+0.19%)
AAPL   143.99 (+0.94%)
MSFT   247.33 (-0.03%)
META   116.77 (+1.25%)
GOOGL   93.64 (-0.07%)
AMZN   89.65 (-0.77%)
TSLA   180.68 (+4.17%)
NVDA   173.09 (+0.82%)
NIO   12.76 (-4.85%)
BABA   91.55 (-2.78%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.56 (+0.65%)
CGC   2.91 (-5.83%)
F   13.24 (+0.91%)
GE   82.10 (-1.83%)
DIS   94.03 (+1.60%)
AMC   5.89 (-2.97%)
PYPL   73.88 (-0.46%)
PFE   51.95 (+0.33%)
NFLX   322.75 (+4.03%)
S&P 500   3,956.28 (-0.18%)
DOW   33,659.02 (-0.36%)
QQQ   284.39 (+0.19%)
AAPL   143.99 (+0.94%)
MSFT   247.33 (-0.03%)
META   116.77 (+1.25%)
GOOGL   93.64 (-0.07%)
AMZN   89.65 (-0.77%)
TSLA   180.68 (+4.17%)
NVDA   173.09 (+0.82%)
NIO   12.76 (-4.85%)
BABA   91.55 (-2.78%)
AMD   69.50 (-1.38%)
T   19.20 (+0.42%)
MU   55.56 (+0.65%)
CGC   2.91 (-5.83%)
F   13.24 (+0.91%)
GE   82.10 (-1.83%)
DIS   94.03 (+1.60%)
AMC   5.89 (-2.97%)
PYPL   73.88 (-0.46%)
PFE   51.95 (+0.33%)
NFLX   322.75 (+4.03%)
NYSE:VAPO

Vapotherm - VAPO Stock Forecast, Price & News

$1.81
+0.42 (+30.22%)
(As of 12/9/2022 03:20 PM ET)
Add
Compare
Today's Range
$1.39
$1.92
50-Day Range
$0.48
$2.11
52-Week Range
$0.46
$24.23
Volume
12,185 shs
Average Volume
1.29 million shs
Market Capitalization
$48.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.75

Vapotherm MarketRank™ Forecast

Analyst Rating
Hold
1.80 Rating Score
Upside/​Downside
174.6% Upside
$4.75 Price Target
Short Interest
Healthy
1.76% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.02mentions of Vapotherm in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$634,560 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.63) to ($1.25) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars

Medical Sector

467th out of 1,022 stocks

Surgical & Medical Instruments Industry

53rd out of 101 stocks

VAPO stock logo

About Vapotherm (NYSE:VAPO) Stock

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Receive VAPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.

VAPO Stock News Headlines

Vapotherm Announces Amendment to Debt Agreement
Vapotherm Recent Insider Activity
Why Vapotherm Shares Are Plunging Today?
Vapotherm Reports Third Quarter 2022 Financial Results
Vapotherm to Report Third Quarter 2022 Financial Results
Vapotherm: Q2 Earnings Snapshot
Where Vapotherm Stands With Analysts
See More Headlines
Receive VAPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.

VAPO Company Calendar

Last Earnings
11/03/2021
Today
12/09/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
510
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.75
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+162.4%
Consensus Rating
Hold
Rating Score (0-4)
1.80
Research Coverage
5 Analysts

Profitability

Net Income
$-59,800,000.00
Net Margins
-156.83%
Pretax Margin
-156.84%

Debt

Sales & Book Value

Annual Sales
$113.29 million
Book Value
$2.56 per share

Miscellaneous

Free Float
23,875,000
Market Cap
$48.35 million
Optionable
Not Optionable
Beta
-0.09

Key Executives

  • Mr. Joseph F. Army CPA (Age 58)
    CPA, CEO, Pres & Director
    Comp: $1.61M
  • Mr. John LandryMr. John Landry (Age 49)
    Sr. VP, CFO & Treasurer
    Comp: $772.21k
  • Mr. Gregoire RamadeMr. Gregoire Ramade (Age 52)
    Sr. VP & Chief Commercial Officer
    Comp: $936.74k
  • Mr. William Niland
    Founder
  • Ms. Dorota Mckay (Age 40)
    Chief Accounting Officer & Controller
  • Mr. Brian Lawrence (Age 52)
    Sr. VP & CTO
  • Mr. Anthony Ten Haagen
    VP of Legal & Compliance
  • Mr. James A. Lightman (Age 64)
    Sr. VP, Gen. Counsel & Sec.
  • Ms. Lindsay Becker (Age 37)
    VP of HR
  • Dr. Michael C. McQueen FAAP (Age 62)
    M.D., MBA, Sr. VP & Chief Medical Officer













VAPO Stock - Frequently Asked Questions

Should I buy or sell Vapotherm stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last twelve months. There are currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" VAPO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VAPO, but not buy additional shares or sell existing shares.
View VAPO analyst ratings
or view top-rated stocks.

What is Vapotherm's stock price forecast for 2023?

5 equities research analysts have issued 12-month price objectives for Vapotherm's shares. Their VAPO share price forecasts range from $2.00 to $7.00. On average, they anticipate the company's stock price to reach $4.75 in the next twelve months. This suggests a possible upside of 239.3% from the stock's current price.
View analysts price targets for VAPO
or view top-rated stocks among Wall Street analysts.

How have VAPO shares performed in 2022?

Vapotherm's stock was trading at $20.71 at the beginning of 2022. Since then, VAPO stock has decreased by 93.2% and is now trading at $1.40.
View the best growth stocks for 2022 here
.

Are investors shorting Vapotherm?

Vapotherm saw a increase in short interest in October. As of October 31st, there was short interest totaling 369,300 shares, an increase of 16.5% from the October 15th total of 317,000 shares. Based on an average daily volume of 185,700 shares, the short-interest ratio is currently 2.0 days. Approximately 1.6% of the shares of the company are sold short.
View Vapotherm's Short Interest
.

When is Vapotherm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our VAPO earnings forecast
.

How were Vapotherm's earnings last quarter?

Vapotherm, Inc. (NYSE:VAPO) announced its quarterly earnings results on Wednesday, November, 3rd. The company reported ($0.52) EPS for the quarter, missing analysts' consensus estimates of ($0.50) by $0.02. The firm had revenue of $38.12 million for the quarter, compared to the consensus estimate of $32.56 million. Vapotherm had a negative trailing twelve-month return on equity of 284.08% and a negative net margin of 156.83%. During the same period last year, the company earned ($0.49) earnings per share.

What guidance has Vapotherm issued on next quarter's earnings?

Vapotherm issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $64.00 million-$66.00 million, compared to the consensus revenue estimate of $73.94 million.

What is Joe Army's approval rating as Vapotherm's CEO?

65 employees have rated Vapotherm Chief Executive Officer Joe Army on Glassdoor.com. Joe Army has an approval rating of 93% among the company's employees. This puts Joe Army in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU), Block (SQ), Taiwan Semiconductor Manufacturing (TSM), Synaptics (SYNA), VBI Vaccines (VBIV) and

When did Vapotherm IPO?

(VAPO) raised $60 million in an IPO on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Vapotherm's stock symbol?

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

Who are Vapotherm's major shareholders?

Vapotherm's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (4.63%), Parian Global Management LP (4.40%), Balyasny Asset Management LLC (3.61%), Taylor Frigon Capital Management LLC (3.50%), Marshall Wace LLP (1.01%) and Requisite Capital Management LLC (0.33%). Insiders that own company stock include 3X5 Partners, Llc, Anthony L Arnerich, Brian Lawrence, Craig B Reynolds, Elizabeth H Weatherman, Gregoire Ramade, James W Liken, James W Liken, Joel F Dube, John Landry, Joseph Army, Marina Hahn, Prescott General Partners Llc and Thomas W Smith.
View institutional ownership trends
.

How do I buy shares of Vapotherm?

Shares of VAPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vapotherm's stock price today?

One share of VAPO stock can currently be purchased for approximately $1.40.

How much money does Vapotherm make?

Vapotherm (NYSE:VAPO) has a market capitalization of $37.39 million and generates $113.29 million in revenue each year. The company earns $-59,800,000.00 in net income (profit) each year or ($4.17) on an earnings per share basis.

How many employees does Vapotherm have?

The company employs 510 workers across the globe.

How can I contact Vapotherm?

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The official website for the company is www.vapotherm.com. The company can be reached via phone at (866) 410-9986 or via email at ir@vtherm.com.

This page (NYSE:VAPO) was last updated on 12/9/2022 by MarketBeat.com Staff